FDA Approved 55 New Treatments in 2023

In 2023, the U.S. Food and Drug Administration (FDA) increased their approvals by 50% since 2022, approving 55 new treatments. On average, the FDA typically approves 45-50 drugs every year. The number of approved drugs depends upon the complexity of newly developed drugs and the advancements in the understanding of …

RSV Injection for Infants Approved

RSV Injection for Infants Approved

On July 17, 2023, the Food and Drug Administration approved an injectable drug designed to protect children up to 2 years of age from respiratory syncytial virus (RSV). The Centers for Disease Control and Prevention’s (CDC) Advisory Committee for Immunization Practices is set to meet to determine who should be …

988 hotline one year after implementation

What are Biosimilars?

A biosimilar drug is a biological product that comes from living organisms (i.e., humans, animals, and microorganisms). Biosimilars are not identical to brand-name counterparts and are not made from synthesized chemicals, unlike generic drugs. It’s noteworthy that biologics and biosimilars have the same strength, dosage, potential side effects, and same …